The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions
Open accessAbstract
Cancer cells in poorly vascularized tumor regions need to adapt to an unfavorable metabolic microenvironment. As distance from supplying blood vessels increases, oxygen and nutrient concentrations decrease and cancer cells react by stopping cell cycle progression and becoming dormant. As cytostatic drugs mainly target proliferating cells, cancer cell dormancy is considered as a major resistance mechanism to this class of anti-cancer drugs. Therefore, substances that target cancer cells in poorly vascularized tumor regions have the potential to enhance cytostatic-based chemotherapy of solid tumors. With three-dimensional growth conditions, multicellular tumor spheroids (MCTS) reproduce several parameters of the tumor microenvironment, including oxygen and nutrient gradients as well as the development of dormant tumor regions. We here report the setup of a 3D cell culture compatible high-content screening system and the identification of nine substances from two commercially available drug libraries that specifically target cells in inner MCTS core regions, while cells in outer MCTS regions or in 2D cell culture remain unaffected. We elucidated the mode of action of the identified compounds as inhibitors of the respiratory chain and show that induction of cell death in inner MCTS core regions critically depends on extracellular glucose concentrations. Finally, combinational treatment with cytostatics showed increased induction of cell death in MCTS. The data presented here shows for the first time a high-content based screening setup on 3D tumor spheroids for the identification of substances that specifically induce cell death in inner tumor spheroid core regions. This validates the approach to use 3D cell culture screening systems to identify substances that would not be detectable by 2D based screening in otherwise similar culture conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 2×
“reported cancer-protective effect [27] of metformin could be induced by a combination of both, inhibition of complex I and additionally lowering blood glucose levels.”
BackgroundDrug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116 · cited 3×
“Similar to native tumor tissue, cells cultured as multicellular tumor spheroids (MCTS) show strong proliferation gradients that reflect distribution gradients of oxygen, nutrients and energy, as well as the accumulation of metabolites from outer to inner spheroid regions [3,4,11–13].”
BackgroundIntra-tumour heterogeneity: a looking glass for cancer?
Marusyk, A., Almendro, V., & Polyak, K. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3261 · Cited by 2,000
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803 · cited 2×
“Similar to native tumor tissue, cells cultured as multicellular tumor spheroids (MCTS) show strong proliferation gradients that reflect distribution gradients of oxygen, nutrients and energy, as well as the accumulation of metabolites from outer to inner spheroid regions [3,4,11–13].”
BackgroundSpheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Models, mechanisms and clinical evidence for cancer dormancy
Aguirre-Ghiso, J. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2256 · Cited by 1,677
Multicellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
Mitochondria and neuronal survival
Nicholls, D. G., & Budd, S. L. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.1.315 · Cited by 1,243
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B. J., Viollet, B., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.001 · Cited by 911
Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
Haq, R., Shoag, J., Andreu-Perez, P., Yokoyama, S., Edelman, H., Rowe, G. C., Frederick, D. T., Hurley, A. D., Nellore, A., Kung, A. L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.003 · Cited by 818
Vazquez, F., Lim, J.-H., Chim, H., Bhalla, K., Girnun, G., Pierce, K., Clish, C. B., Granter, S. R., Widlund, H. R., Spiegelman, B. M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.020 · Cited by 715
Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis
Ivascu, A., & Kubbies, M. (2006) · SLAS Discovery · doi:10.1177/1087057106292763 · Cited by 597
High-resolution three-dimensional imaging of large specimens with light sheet–based microscopy
Verveer, P. J., Swoger, J., Pampaloni, F., Greger, K., Marcello, M., & Stelzer, E. H. K. (2007) · Nature Methods · doi:10.1038/nmeth1017 · Cited by 361
Self-citationAwale, S., Lu, J., Kalauni, S. K., Kurashima, Y., Tezuka, Y., Kadota, S., & Esumi, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3143 · Cited by 330
Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence
Páez, D., Labonte, M. J., Bohanes, P., Zhang, W., Benhanim, L., Ning, Y., Wakatsuki, T., Loupakis, F., & Lenz, H.-J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2186 · Cited by 215
Glucose diffusivity in multicellular tumor spheroids.
Casciari, J. J., Sotirchos, S. V., & Sutherland, R. M. (1988) · PubMed · Cited by 166
Sahra, I. B., Tanti, J., & Bost, F. (2010) · Autophagy · doi:10.4161/auto.6.5.12434 · Cited by 120
Lu, J., Kunimoto, S., Yamazaki, Y. M., Kaminishi, M., & Esumi, H. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03247.x · Cited by 108
Microregional Effects of Gemcitabine in HCT-116 Xenografts
Huxham, L. A., Kyle, A. H., Baker, J. H. E., Nykilchuk, L. K., & Minchinton, A. I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0986 · Cited by 79
LaRue, K. E., Khalil, M., & Freyer, J. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2902-2 · Cited by 69
Metabolic response to low-level toxicant exposure in a novel renal tubuleepithelial cell system
Ellis, J. K., Athersuch, T. J., Cavill, R., Radford, R., Slattery, C., Jennings, P., McMorrow, T., Ryan, M. P., Ebbels, T. M. D., & Keun, H. C. (2010) · Molecular BioSystems · doi:10.1039/c0mb00146e · Cited by 55
Targeting Quiescent Tumor Cells via Oxygen and IGF-I Supplementation
Kyle, A. H., Baker, J. H. E., & Minchinton, A. I. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-3059 · Cited by 36
Quiescent cells: A natural way to resist chemotherapy
Menchón, S. A., & Condat, C. A. (2011) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2011.05.009 · Cited by 14
Cited by
Understanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293
3D tumor spheroids: an overview on the tools and techniques used for their analysis
Costa, E. C., Moreira, A. F., de Melo-Diogo, D., Gaspar, V. M., Carvalho, M. P., & Correia, I. J. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.11.002 · Cited by 929
Three-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849
“Similar results were obtained from the HCS of 1120 compounds against spheroids of the human breast cancer cell line T47D.(106) At the 2016 SLAS annual conference, Dr.”
ResultTargeted photoredox catalysis in cancer cells
Huang, H., Banerjee, S., Qiu, K., Zhang, P., Blacque, O., Malcomson, T., Paterson, M. J., Clarkson, G. J., Staniforth, M., Stavros, V. G., et al. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0328-4 · Cited by 539
Screening out irrelevant cell-based models of disease
Horvath, P., Aulner, N., Bickle, M., Davies, A. M., Nery, E. D., Ebner, D., Montoya, M. C., Östling, P., Pietiäinen, V., Price, L. S., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.175 · Cited by 525
Self-citation
Metadata
- Authors
- Wenzel, C., Riefke, B., Gründemann, S., Krebs, A., Christian, S., Prinz, F., Osterland, M., Golfier, S., Räse, S., Ansari, N., Esner, M., Bickle, M., Pampaloni, F., Mattheyer, C., Stelzer, E. H., Parczyk, K., Prechtl, S., & Steigemann, P.
- Venue
- Experimental Cell Research
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 323
- Issue
- 1
- Pages
- 131-143
- ISSN
- 0014-4827 (ISSN-L)
- OpenAlex
- W1994659121
- Cited by
- 254
- References
- 26
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.